S&P 500   3,970.99 (+0.56%)
DOW   32,237.53 (+0.41%)
QQQ   310.89 (+0.37%)
AAPL   160.25 (+0.83%)
MSFT   280.57 (+1.05%)
META   206.01 (+0.85%)
GOOGL   105.44 (-0.15%)
AMZN   98.13 (-0.59%)
TSLA   190.41 (-0.94%)
NVDA   267.79 (-1.52%)
NIO   9.07 (-2.16%)
BABA   86.90 (+0.44%)
AMD   97.95 (-2.32%)
T   18.61 (+0.81%)
F   11.51 (+0.79%)
MU   61.16 (-0.29%)
CGC   1.90 (-0.52%)
GE   91.37 (-0.24%)
DIS   94.08 (-1.83%)
AMC   4.47 (+0.00%)
PFE   40.39 (+0.52%)
PYPL   73.88 (+1.82%)
NFLX   328.39 (+2.50%)
S&P 500   3,970.99 (+0.56%)
DOW   32,237.53 (+0.41%)
QQQ   310.89 (+0.37%)
AAPL   160.25 (+0.83%)
MSFT   280.57 (+1.05%)
META   206.01 (+0.85%)
GOOGL   105.44 (-0.15%)
AMZN   98.13 (-0.59%)
TSLA   190.41 (-0.94%)
NVDA   267.79 (-1.52%)
NIO   9.07 (-2.16%)
BABA   86.90 (+0.44%)
AMD   97.95 (-2.32%)
T   18.61 (+0.81%)
F   11.51 (+0.79%)
MU   61.16 (-0.29%)
CGC   1.90 (-0.52%)
GE   91.37 (-0.24%)
DIS   94.08 (-1.83%)
AMC   4.47 (+0.00%)
PFE   40.39 (+0.52%)
PYPL   73.88 (+1.82%)
NFLX   328.39 (+2.50%)
S&P 500   3,970.99 (+0.56%)
DOW   32,237.53 (+0.41%)
QQQ   310.89 (+0.37%)
AAPL   160.25 (+0.83%)
MSFT   280.57 (+1.05%)
META   206.01 (+0.85%)
GOOGL   105.44 (-0.15%)
AMZN   98.13 (-0.59%)
TSLA   190.41 (-0.94%)
NVDA   267.79 (-1.52%)
NIO   9.07 (-2.16%)
BABA   86.90 (+0.44%)
AMD   97.95 (-2.32%)
T   18.61 (+0.81%)
F   11.51 (+0.79%)
MU   61.16 (-0.29%)
CGC   1.90 (-0.52%)
GE   91.37 (-0.24%)
DIS   94.08 (-1.83%)
AMC   4.47 (+0.00%)
PFE   40.39 (+0.52%)
PYPL   73.88 (+1.82%)
NFLX   328.39 (+2.50%)
S&P 500   3,970.99 (+0.56%)
DOW   32,237.53 (+0.41%)
QQQ   310.89 (+0.37%)
AAPL   160.25 (+0.83%)
MSFT   280.57 (+1.05%)
META   206.01 (+0.85%)
GOOGL   105.44 (-0.15%)
AMZN   98.13 (-0.59%)
TSLA   190.41 (-0.94%)
NVDA   267.79 (-1.52%)
NIO   9.07 (-2.16%)
BABA   86.90 (+0.44%)
AMD   97.95 (-2.32%)
T   18.61 (+0.81%)
F   11.51 (+0.79%)
MU   61.16 (-0.29%)
CGC   1.90 (-0.52%)
GE   91.37 (-0.24%)
DIS   94.08 (-1.83%)
AMC   4.47 (+0.00%)
PFE   40.39 (+0.52%)
PYPL   73.88 (+1.82%)
NFLX   328.39 (+2.50%)
NASDAQ:HSKA

Heska - HSKA Stock Forecast, Price & News

$92.44
+3.24 (+3.63%)
(As of 03/24/2023 04:28 PM ET)
Add
Compare
Today's Range
$87.54
▼
$92.61
50-Day Range
$78.46
▼
$93.15
52-Week Range
$57.83
▼
$149.17
Volume
95,714 shs
Average Volume
124,106 shs
Market Capitalization
$1.01 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$121.75

Heska MarketRank™ Forecast

Analyst Rating
Moderate Buy
2.50 Rating Score
Upside/​Downside
31.7% Upside
$121.75 Price Target
Short Interest
Bearish
5.28% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
N/A
Insider Trading
Acquiring Shares
$645,875 Bought Last Quarter
Proj. Earnings Growth
250.00%
From $0.30 to $1.05 Per Share

Overall MarketRank™

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.47 out of 5 stars

Medical Sector

118th out of 989 stocks

Diagnostic Substances Industry

2nd out of 14 stocks

See Top Rated MarketRank™ Stocks Here

HSKA stock logo

About Heska (NASDAQ:HSKA) Stock

Heska Corp. engages in the provision of veterinary and animal health diagnostic, and specialty products. It operates through the North America and International segments. The North America segment includes the United States, Canada, and Mexico. The International segment involves Australia, France, Germany, Italy, Malaysia, Spain, and Switzerland. The company was founded by Robert B. Grieve and Lynnor B. Stevenson in 1988 and is headquartered in Loveland, CO.

Receive HSKA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Heska and its competitors with MarketBeat's FREE daily newsletter.

HSKA Stock News Headlines

March 1, 2023 | finance.yahoo.com
Heska (HSKA) Q4 Earnings and Revenues Surpass Estimates
March 1, 2023 | finance.yahoo.com
Heska Full Year 2022 Earnings: EPS Misses Expectations
March 24, 2023 | Weiss Ratings (Ad)
Bank Accounts: Frozen!
In 1990, the Brazilian government froze the bank accounts of thousands of citizens. In 2013, the victims were the people of Cyprus. In 2022, it hit closer to home — in Canada. And now the Federal Reserve System Docket No. OP-1670 reveals the plan to give the Fed the power to track and potentially even control your checking account. Not just the money you have in your account … But also, every single check, withdrawal, deposit and transaction. Practically everything you do with your money!
March 1, 2023 | finance.yahoo.com
At US$81.43, Is It Time To Put Heska Corporation (NASDAQ:HSKA) On Your Watch List?
February 28, 2023 | finance.yahoo.com
Heska Corporation Reports Fourth Quarter and Full Year 2022 Results
February 23, 2023 | finance.yahoo.com
Heska to Present at Three Upcoming Institutional Investor Conferences
February 13, 2023 | finance.yahoo.com
Heska (HSKA) Moves to Buy: Rationale Behind the Upgrade
February 8, 2023 | finance.yahoo.com
Heska Fourth Quarter and Full Year 2022 Financial Results and Earnings Call Scheduled for February 28, 2023
March 24, 2023 | Weiss Ratings (Ad)
Bank Accounts: Frozen!
In 1990, the Brazilian government froze the bank accounts of thousands of citizens. In 2013, the victims were the people of Cyprus. In 2022, it hit closer to home — in Canada. And now the Federal Reserve System Docket No. OP-1670 reveals the plan to give the Fed the power to track and potentially even control your checking account. Not just the money you have in your account … But also, every single check, withdrawal, deposit and transaction. Practically everything you do with your money!
January 18, 2023 | finance.yahoo.com
Is There An Opportunity With Heska Corporation's (NASDAQ:HSKA) 50% Undervaluation?
January 11, 2023 | finance.yahoo.com
Heska (HSKA) Moves 9.0% Higher: Will This Strength Last?
January 3, 2023 | finance.yahoo.com
Heska Corporation Completes Acquisition of LightDeck Diagnostics
December 23, 2022 | finance.yahoo.com
Heska to Participate in the 41st J.P. Morgan Annual Healthcare Conference
November 8, 2022 | finance.yahoo.com
Heska Corporation Reports Third Quarter 2022 Results
November 8, 2022 | finance.yahoo.com
Heska (HSKA) Q3 Earnings and Revenues Lag Estimates
November 8, 2022 | finance.yahoo.com
Will Heska Corporation (HSKA) Overcome the Current Challenges?
November 1, 2022 | finance.yahoo.com
Heska (HSKA) Reports Next Week: Wall Street Expects Earnings Growth
October 19, 2022 | globenewswire.com
NORDIC Veterinary Diagnostics Market to Garner around USD 167 Million by 2031 and to Grow with a CAGR of ~7% during 2022-2031; Rising Number of Pets to Elevate Market Growth – Kenneth Research - GlobeNewswire
October 18, 2022 | globenewswire.com
Global Veterinary Vaccines Market to Reach $13.3 Billion by 2027 - GlobeNewswire
October 18, 2022 | benzinga.com
Heska Third Quarter 2022 Financial Results and Earnings Call Scheduled for November 8, 2022 - Heska (NASD - Benzinga
October 18, 2022 | finance.yahoo.com
Heska Third Quarter 2022 Financial Results and Earnings Call Scheduled for November 8, 2022
October 12, 2022 | businesswire.com
Veterinary Diagnostics Market Report 2022: Growing Prevalence of Zoonotic Diseases to Drive Growth - ResearchAndMarkets.com - Business Wire
October 11, 2022 | finance.yahoo.com
The past year for Heska (NASDAQ:HSKA) investors has not been profitable
October 6, 2022 | finance.yahoo.com
Demand for Global Animal Health Market Size to Surpass USD 87.07 Billion by 2026, Exhibit a CAGR of 8.7% - Comprehensive Research Report by Facts & Factors - Yahoo Finance
October 2, 2022 | reuters.com
HSKA.OQ - Heska Corp | Stock Price & Latest News | Reuters
September 30, 2022 | finance.yahoo.com
Veterinary Infectious Disease Diagnostics Global Market Report 2022: Featuring Zoetis, IDEXX, Thermo Fisher, Randox & Others - Yahoo Finance
September 22, 2022 | reuters.com
HSKA.O - Heska Corp | Stock Price & Latest News | Reuters
See More Headlines
Receive HSKA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Heska and its competitors with MarketBeat's FREE daily newsletter.

HSKA Company Calendar

Last Earnings
11/04/2021
Today
3/24/2023
Next Earnings (Estimated)
5/08/2023
Fiscal Year End
12/31/2023
Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
Diagnostic substances
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:HSKA
CUSIP
N/A
CIK
1038133
Web
www.heska.com
Phone
(970) 493-7272
Fax
970-619-3003
Employees
655
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$121.75
High Stock Price Forecast
$150.00
Low Stock Price Forecast
$58.00
Forecasted Upside/Downside
+34.2%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.50
Research Coverage
4 Analysts

Profitability

EPS (Most Recent Fiscal Year)
($1.93)
Trailing P/E Ratio
N/A
Forward P/E Ratio
302.30
P/E Growth
N/A
Net Income
$-19,890,000.00
Net Margins
-7.73%
Pretax Margin
-8.49%
Return on Equity
0.57%
Return on Assets
0.41%

Debt

Debt-to-Equity Ratio
0.23
Current Ratio
6.70
Quick Ratio
5.18

Sales & Book Value

Annual Sales
$257.31 million
Price / Sales
3.83
Cash Flow
$1.70 per share
Price / Cash Flow
53.46
Book Value
$39.00 per share
Price / Book
2.33

Miscellaneous

Outstanding Shares
10,880,000
Free Float
9,680,000
Market Cap
$986.71 million
Optionable
Not Optionable
Beta
1.53

Key Executives

  • Kevin S. WilsonKevin S. Wilson
    President, Chief Executive Officer & Director
  • Nancy Wisnewski
    Chief Operating Officer & Executive Vice President
  • Catherine I. GrassmanCatherine I. Grassman
    Chief Financial Officer & Executive Vice President
  • Glenn R. Frank
    Vice President-Research & Development
  • Steven M. Eyl
    Chief Commercial Officer & Executive VP

Key Competitors

View All Competitors

Insiders & Institutions

View All Insider Transactions
View All Institutional Transactions













HSKA Stock - Frequently Asked Questions

Should I buy or sell Heska stock right now?

4 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Heska in the last twelve months. There are currently 1 sell rating and 3 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" HSKA shares.
View HSKA analyst ratings or view top-rated stocks.

What is Heska's stock price forecast for 2023?

4 Wall Street research analysts have issued 12-month target prices for Heska's shares. Their HSKA share price forecasts range from $58.00 to $150.00. On average, they anticipate the company's stock price to reach $121.75 in the next year. This suggests a possible upside of 31.7% from the stock's current price.
View analysts price targets for HSKA or view top-rated stocks among Wall Street analysts.

How have HSKA shares performed in 2023?

Heska's stock was trading at $62.16 at the start of the year. Since then, HSKA stock has increased by 48.7% and is now trading at $92.44.
View the best growth stocks for 2023 here.

When is Heska's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Monday, May 8th 2023.
View our HSKA earnings forecast.

How were Heska's earnings last quarter?

Heska Co. (NASDAQ:HSKA) issued its quarterly earnings data on Thursday, November, 4th. The medical research company reported ($0.19) earnings per share (EPS) for the quarter, missing the consensus estimate of $0.04 by $0.23. The medical research company earned $60.24 million during the quarter, compared to analyst estimates of $63.80 million. Heska had a negative net margin of 7.73% and a positive trailing twelve-month return on equity of 0.57%. The business's quarterly revenue was up 6.4% on a year-over-year basis. During the same period in the prior year, the firm posted ($0.25) earnings per share.

What ETFs hold Heska's stock?

ETFs with the largest weight of Heska (NASDAQ:HSKA) stock in their portfolio include Motley Fool Small-Cap Growth ETF (TMFS), MFAM Small-Cap Growth ETF (MFMS), ProShares Pet Care ETF (PAWZ), SPDR S&P Health Care Equipment ETF (XHE), Motley Fool Mid-Cap Growth ETF (TMFM), Invesco S&P SmallCap Health Care ETF (PSCH), BlackRock Future Health ETF (BMED) and Inspire Small/Mid Cap ETF (ISMD).

What guidance has Heska issued on next quarter's earnings?

Heska issued an update on its FY 2023 earnings guidance on Tuesday, February, 28th. The company provided EPS guidance of for the period. The company issued revenue guidance of $278.00 million-$288.00 million, compared to the consensus revenue estimate of $278.56 million.

What is Kevin S. Wilson's approval rating as Heska's CEO?

5 employees have rated Heska Chief Executive Officer Kevin S. Wilson on Glassdoor.com. Kevin S. Wilson has an approval rating of 57% among the company's employees. This puts Kevin S. Wilson in the bottom 25% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of Heska own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Heska investors own include Gilead Sciences (GILD), Exxon Mobil (XOM), Netflix (NFLX), Biogen (BIIB), AbbVie (ABBV), Amgen (AMGN), Broadcom (AVGO), Alibaba Group (BABA), Exelixis (EXEL) and Merck & Co., Inc. (MRK).

What is Heska's stock symbol?

Heska trades on the NASDAQ under the ticker symbol "HSKA."

Who are Heska's major shareholders?

Heska's stock is owned by a variety of retail and institutional investors. Top institutional investors include Fred Alger Management LLC (4.96%), abrdn plc (3.70%), Riverbridge Partners LLC (2.92%), Bank of America Corp DE (2.29%), Dimensional Fund Advisors LP (2.20%) and TimesSquare Capital Management LLC (2.16%). Insiders that own company stock include Bonnie J Trowbridge, Catherine Grassman, Jason D Aroesty, Kevin S Wilson, Nancy Wisnewski and Sharon J Larson.
View institutional ownership trends.

How do I buy shares of Heska?

Shares of HSKA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Heska's stock price today?

One share of HSKA stock can currently be purchased for approximately $92.44.

How much money does Heska make?

Heska (NASDAQ:HSKA) has a market capitalization of $1.01 billion and generates $257.31 million in revenue each year. The medical research company earns $-19,890,000.00 in net income (profit) each year or ($1.93) on an earnings per share basis.

How many employees does Heska have?

The company employs 655 workers across the globe.

How can I contact Heska?

Heska's mailing address is 3760 ROCKY MOUNTAIN AVENUE, LOVELAND CO, 80538. The official website for the company is www.heska.com. The medical research company can be reached via phone at (970) 493-7272, via email at investorrelations@heska.com, or via fax at 970-619-3003.

This page (NASDAQ:HSKA) was last updated on 3/24/2023 by MarketBeat.com Staff